Cervical Cancer / HPV Vaccine News From Medical News Today Latest Health News and Medical News posted throughout the day, every day.
Washington Post, 'Marketplace' Examine Issues Related To HPV Vaccines
The Washington Post on Tuesday published a list of questions and answers from a Consumer Reports review of the safety and efficacy of Merck's human papillomavirus vaccine, Gardasil...
mtm Laboratories Announces The European Launch Of CINtec(R) PLUS
mtm laboratories, a privately held diagnostics company announced the launch of CINtec® PLUS, the company's next generation cervical cancer screening product with unmatched accuracy for the screening and management for cervical cancer...
Sociodemographic Characteristics Are Related To A Patient's Willingness To Participate In Cancer Screenings
Boston University School of Medicine's (BUSM) researchers have found that sociodemographic characteristics are related to a patients' willingness to participate in cancer screenings. They found this was more important than both attitudinal barriers and medical facilitors. This study appears in the March issue of the Journal of the National Medical Association...
PadKit(R) Collection System Selected By UCLA School Of Nursing For Its Grant Funded Cervical Cancer Study
CytoCore Inc...
Study Of Costa Rican Women Shows HPV Vaccine Of Little Benefit To Women Over Age 40
Women older than age 40 are not likely to receive a substantial benefit from vaccination against the human papillomavirus, according to a study published in the Journal of the National Cancer Institute, the New York Times reports...
Top Doctors To Present Results Of FDA Clinical Trial Of Guided Therapeutics' Cervical Cancer Detection Technology At Scientific Meeting
Results of the U.S. Food and Drug Administration (FDA) pivotal clinical trial for the Guided Therapeutics, Inc. (GT) (Pink Sheets: GTHP) LightTouchâ„¢ Non-invasive Cervical Cancer Detection System are scheduled to be presented by five leading doctors at the American Society for Colposcopy and Cervical Pathology biennial meeting, March 24 - 27, 2010, in Las Vegas...
Survey Finds States Limiting Breast, Cervical Cancer Screening Services
A survey released Monday of 150 breast cancer health educators and providers from 48 states and Washington, D.C., found that roughly one-fourth say their states have limited mammography services and other early detection programs for women younger than age 50 since the U.S...
News Outlets Examine HIV Vaccine Research, Cervical Cancer Screening Data Presented At Conference
Several news outlets examine the latest reports out of this week's Conference on Retroviruses and Opportunistic Infections (CROI) in San Francisco. Researchers from the Maryland-based VIRxSYS Corporation on Thursday presented data on the outcomes of the company's HIV vaccine, VRX1023, from a recent trial carried out in monkeys, Reuters reports...
UF Veterinarians Say Dolphins Could Be Ideal Model To Study Human Cervical Cancer
After testing dozens of samples from marine mammals, University of Florida aquatic animal health experts say dolphins may be the ideal model for the study of cervical cancer in people...
Preliminary Data From Roche ATHENA Cervical Cancer Trial Support Value Of Human Papillomavirus Genotyping
Roche Molecular Systems, Inc. (SIX: RO, ROG; OTCQX: RHHBY) announced that preliminary data from its ATHENA (Addressing THE Need for Advanced HPV Diagnostics) trial support the importance of screening for human papillomavirus (HPV) genotypes that put women at highest risk for developing cervical cancer. ATHENA is a prospective, double-blind, multi-centered, 47,000-patient, U.S...
Gardasil Effective In Women Ages 25 To 45, Young Men, Merck Studies Show
Merck's human papillomavirus vaccine, Gardasil, effectively prevented precancerous cervical lesions and genital warts in women ages 24 through 45, and it prevented anal cancer and precancerous anal lesions in young men who have sex with men, according to two studies released by the company on Wednesday, the AP/Philadelphia Inquirer reports...
UCLA School Of Nursing Selects QuantRx PadKit(R) Collection System For Grant Funded Cervical Cancer Study
QuantRx® Biomedical Corporation (OTCBB:QTXB), an emerging leader in the development and commercialization of innovative diagnostic products based on its patented technology platforms for the worldwide point-of-care healthcare industry, announced that its proprietary PadKit has been selected as the sample collection system by the UCLA School of Nursing for a comparative cyto...
Benefit Of HPV Vaccination, Frequent Screening For Women Over 41 Is Likely To Be Low
The overall potential benefits of human papillomavirus (HPV) vaccinations or frequent HPV screenings for women over the age of 41 are low, concludes a new study published online February 15 in the Journal of the National Cancer Institute. The study found that the rate of new infections preventable by vaccination declines with age...
UNC Leads Initiative To Eradicate Cervical Cancer; N.C. Governor Applauds Plan
Asserting that no one should die from cervical cancer, public health researchers at the University of North Carolina at Chapel Hill are leading a multi-state initiative to prevent or even eradicate the disease...
Tobacco Use Linked To Worse Outcomes In HPV-Positive Head And Neck Cancer, U-M Study Finds
Patients with head and neck cancer linked to high risk human papillomavirus, or HPV, have worse outcomes if they are current or former tobacco users, according to a new study from researchers at the University of Michigan Comprehensive Cancer Center. High-risk HPVs are the same viruses that are associated with cancers of the uterine cervix...
Helix BioPharma Announces Positive Interim Results From Its Ongoing Phase II Pharmacokinetic Clinical Study Of Topical Interferon Alpha-2b
Helix BioPharma Corp. (TSX, FSE: HBP; Pink Sheets: HXBPF) announced that the first ten patients that have been enrolled in its Phase II pharmacokinetic study of Topical Interferon Alpha-2b in patients with low-grade cervical lesions have completed the pharmacokinetic primary endpoint analyses with positive findings...
Regimen With New Drug Triapine Provides Both Significant Reduction And Control In Cervical Cancer
Researchers at the Ireland Cancer Center of University Hospitals (UH) Case Medical Center, have published new findings that may lead to a new standard of care for patients with locally advanced cervical cancer...
Inovio Biomedical Cervical Cancer Therapeutic Vaccine Generates Dose-Related Immune Response In Clinical Trial
Inovio Biomedical Corporation (NYSE Amex: INO), a leader in DNA vaccine design, development and delivery, announced today additional interim safety and immunogenicity data from its therapeutic cervical cancer vaccine (VGX-3100) trial. VGX-3100 is a DNA vaccine targeting the E6 and E7 proteins of human papillomavirus (HPV) types 16 and 18 and is delivered via in vivo electroporation...
More Smokers Than Non-Smokers Accept HPV Vaccination For Their Daughters
A parent's existing health habits or behaviors, like cigarette smoking, may influence the likelihood that they will have their daughters vaccinated against HPV...
HPV Vaccines May Reduce A Wide Range Of Genital Diseases
High-coverage human papillomavirus (HPV) vaccinations among adolescents and young women may result in a rapid reduction of genital warts, cervical cell abnormalities, and diagnostic and therapeutic procedures, researchers report in a new study published online in the Journal of the National Cancer Institute...
Sen. Hutchison Criticizes Texas Gov. Perry For Supporting HPV Vaccine Requirement For Schools
Sen. Kay Bailey Hutchison (R-Texas) on Tuesday criticized Texas Gov. Rick Perry (R) -- her opponent in the state's Republican gubernatorial primary -- over his executive order three years ago that would have required sixth-grade girls to receive vaccinations against the human papillomavirus, the AP/Dallas Morning News reports...
New Mathematical Model For Curing More Cervical Cancer Cases
Cervical cancer is highly curable when caught early. But in a third of cases, the tumor responds poorly to therapy or recurs later, when cure is much less likely. Quicker identification of non-responding tumors may be possible using a new mathematical model developed by researchers at the Ohio State University Comprehensive Cancer Center-Arthur G. James Cancer Hospital and Richard J...
Texas Invests $4.5 Million In Cancer Research At UT Health Science Center At Houston
Texas plans to invest $3 billion in cancer research over the next 10 years and six scientists at The University of Texas Health Science Center at Houston are among the first to receive grants. The researchers, whose grants total $4...
Blogs Comment On Antiabortion Super Bowl Ad, Health Reform Prospects, Other Topics
The following summarizes selected women's health-related blog entries. ~ "CBS To Air First Super Bowl Abortion Ad," Elizabeth Gettelman, Mother Jones' "Mojo": Former University of Florida quarterback Tim Tebow "is taking televangelism to a whole new level" by appearing with his mother in a Super Bowl commercial sponsored by the antiabortion-rights group Focus on the Family, Gettelman writes...
Get Vaccinated Against HPV, European Cervical Cancer Prevention Week, Wales
During European Cervical Cancer Prevention Week (24 - 30 January) girls and their parents are being reminded of the importance of having the HPV vaccine. The vaccine protects girls against the two types of the Human Papilloma Virus (HPV) believed to cause more than 70 per cent of cervical cancers...
Worlds Best Pharmacy
canadian meds shop
Why is your product so cheap? How do you ship orders? We accept : Visa, MasterCard, AmEx, Diners and JCB cards. |
